
Alagille
syndrome is an inherited disorder that mimics other forms
of prolonged liver disease seen in infants and young children.
However, a group of unusual features in other organ systems
distinguishes Alagille syndrome from other liver and bile
duct diseases in infants.
Children
with Alagille Syndrome usually have a liver disease characterized
by a progressive loss of the bile ducts within the liver over
the first year of life and narrowing of bile ducts outside
the liver. This leads to a buildup of bile in the liver, causing
damage to liver cells. Scarring may occur and lead to cirrhosis
in about 30 to 50 percent of affected children.
Symptoms
of the illness are jaundice, pale, loose stools and poor growth
within the first three months of life. Later there is persistent
jaundice, itching, fatty deposits in the skin and stunted
growth and development during early childhood. Frequently,
the disease stabilizes between ages 4 and 10 with an improvement
in symptoms.
Other
features which help establish the diagnosis include abnormalities
in the cardiovascular system, the spinal column, the eye and
the kidneys. Narrowing of the blood vessel connecting the
heart to the lungs (pulmonary artery) leads to extra heart
sounds but rarely to problems in heart function. The shape
of the bones of the spinal column may look like a butterfly's
wings on X-ray but almost never cause problems with function
of the nerves in the spinal cord.
More
than 90 percent of children with Alagille Syndrome have an
unusual abnormality of the eyes. An extra, circular line on
the surface of the eye requires specialized eye examination
to detect and does not lead to any disturbances in vision.
In addition, some children have various abnormalities in their
kidneys that may lead to minor changes in kidney function.
Many
physicians believe that there is a specific facial appearance
shared by most of the children with Alagille Syndrome that
makes them easily recognizable. The features include a prominent,
broad forehead, deep-set eyes, a straight nose and a small
pointed chin.
Alagille
Syndrome is generally inherited only from one parent and there
is a 50 percent chance that each child will develop the syndrome.
Each affected adult or child may have all or only a few of
the features of the syndrome. Frequently a parent or brother
or sister of the affected child will share the facial appearance,
heart murmur or butterfly vertebrae, but have a completely
normal liver and bile ducts.
Treatment
of Alagille Syndrome is based on trying to increase the flow
of bile from the liver, maintain normal growth and development
and prevent or correct any of the specific nutritional deficiencies
that often develop. Because bile flow from the liver to the
intestine is slow in Alagille Syndrome, medications designed
to increase the flow of bile are frequently prescribed, including
Phenobarbital and Questran or Colistipol. This may decrease
the damage in the liver and improve the digestion of fat in
foods that are eaten.
Also,
itching caused by the buildup of bile in the blood and skin
may be relieved. Other drugs are also used to relieve itching
(Benadryl, Atarax). Elevations in blood cholesterol also respond
to the medications used to increase bile flow. Elevated blood
cholesterol levels can lead to small yellow deposits of cholesterol
on the skin of knees, elbows, palms, eyelids and other surfaces
that are frequently rubbed. Lowering blood cholesterol usually
causes the cholesterol skin deposits to improve; although
these are unsightly, they are almost never associated with
any dangerous symptoms.
Although
reduced flow of bile into the intestine leads to poor digestion
of dietary fat, a specific type of fat can still be well digested
and therefore infant formulas containing high levels of medium-chain
triglycerides (MCT) are usually substituted for conventional
formulas. Trade names are Pregestamil or Portagen. Some infants
can grow adequately on breast milk if additional MCT oil is
given. Foods containing fat may lead to looser, greasy stools
later in childhood. However, the benefits from the calories
and vitamins in the fat that is absorbed usually leads to
the recommendation that the child not be put on a low-fat
diet. There are no other dietary restrictions. Occasionally,
MCT oil is also prescribed as a nutritional supplement.
Problems
with fat digestion and absorption may lead to deficiency of
fat-soluble vitamins--A, D, E and K. Vitamin A deficiency
causes night blindness and red eyes. Vitamin D deficiency
causes softening and fractures of the bones and teeth (rickets).
Vitamin E deficiency causes a disabling disease of the nervous
system and muscles, and vitamin K deficiency causes bleeding
problems. Deficiencies of these vitamins can be diagnosed
by blood tests and usually can be corrected by large oral
doses. If the child's system cannot absorb vitamins given
by mouth, vitamin injections into the muscle are necessary.
Sometimes surgery is necessary during infancy to help establish
the diagnosis of Alagille Syndrome by direct examination of
the bile duct system. However, surgical reconstruction of
the bile duct system is not recommended because bile can still
flow from the liver and there is presently no procedure that
can correct for the loss of the bile ducts within the liver.
Occasionally liver cirrhosis advances to a stage where the
liver fails to perform its functions. Liver transplantation
is then considered.
The
overall life expectancy for children with Alagille Syndrome
is unknown, but depends on several factors: the severity of
scarring in the liver, whether heart or lung problems develop
because of the narrowing in the pulmonary artery, and the
presence of infections or other problems related to poor nutrition.
Many adults with Alagille Syndrome lead normal lives.
Although
Alagille Syndrome was first described in the English medical
literature in 1975, it is now becoming recognized more frequently
among children with chronic forms of liver disease. Diagnosis
can be established by microscopic examination of liver biopsy
specimens, a stethoscope examination of the child's heart
and chest, a slip-lamp eye examination, an X-ray of the spinal
column and an ultrasound (sonogram) examination of the abdomen.
Treatment
is primarily medical and not surgical. Patients generally
have a much better outcome than children with some of the
other liver diseases that may present at the same age.
The
American Liver Foundation is the only national voluntary nonprofit
health organization dedicated to treating, curing, and preventing
hepatitis and other liver and gallbladder diseases through
research and education.
American Liver Foundation
1425 S Avenue
Cedar Grove, NJ 07009
1-800-223-0179
Copyright © 1995 The American Liver Foundation
|